Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 3/2006

01-04-2006 | Original Paper

Decline in Cervical Cancer Incidence and Mortality in New South Wales in Relation to Control Activities (Australia)

Authors: Richard Taylor, Stephen Morrell, Hassan Mamoon, Gerard Wain, Jayne Ross

Published in: Cancer Causes & Control | Issue 3/2006

Login to get access

Abstract

Background

To examine time trends in cervical cancer incidence and mortality in NSW women aged ¥20 years in relation to important health service initiatives and programs.

Methods

Data on cervical cancer incidence and mortality were obtained from the NSW Central Cancer Registry for 1972–2001, and corresponding annual populations obtained from the Australian Bureau of Statistics. Direct age-standardised rates in the ¥20 year population were calculated using the 2001 NSW census population as standard. Proportional reductions in incidence and mortality since 1972–1974 were also calculated and related to key health service factors and to published NSW 5-year cervical cancer relative survival for similar periods.

Results

Declines in cervical cancer incidence (−10%) and mortality (−20%), and increased degree-of-spread specific survival following the introduction of universal health care in 1975 suggest effects of greater access to Pap screening, earlier access to diagnosis and treatment services, and improved effectiveness of treatment. Incidence plateaued during the 1980s, but mortality fell further (−7%) due to an increased proportion of localised cancers (without change to degree-of-spread specific survival). The 1980s mortality reduction was a consequence of earlier diagnosis and/or secondary prevention, not improved treatment effectiveness or reduced incidence. A marked and sustained incidence decline to 2001 (−35%) occurred after the introduction of the NSW Cervical Screening Program in 1992. This was followed 3 years later by a sustained mortality decline (−20%). During the 1990s survival across all degrees of spread remained unchanged and the mortality reduction was due entirely to reduction in incidence.

Conclusions

The substantial reduction of cervical cancer incidence and mortality in NSW over the last 3 decades is associated with important health service interventions that relate to control of cervical cancer, particularly the implementation of a population-based organised cervical screening program.
Literature
1.
Sigurdsson, K, Hrafnkelsson, J, Geirsson, G,  et al. 1991Screening as a prognostic factor in cervical cancer: analysis of survival and prognostic factors based on Icelandic population data, 1964–1988Gynecol Oncol436470CrossRefPubMed
2.
Adami, HO, Ponten, J, Sparen, P,  et al. 1994Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening. 1960–1984Cancer73140147PubMed
3.
International Agency for Research on Cancer [IARC]1986Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implications for screening policiesBMJ293659664
4.
Johannesson, G, Geirsson, G, Day, N 1978The effect of mass screening in Iceland, 1965–74, on the incidence and mortality of cervical carcinomaInt J Cancer21418425PubMed
5.
Johannesson, G, Geirsson, G, Day, N,  et al. 1982Screening for cancer of the uterine cervix in Iceland 1965–1978Acta Obstet Gynecol Scand61199203PubMed
6.
Sigurdsson, K 1993Effect of organized screening on the risk of cervical cancer: evaluation of screening activity in Iceland, 1964–1991Int J Cancer54563570PubMed
7.
Day, N 1984Effect of cervical cancer screening in ScandinaviaObstet Gynecol63714718PubMed
8.
Hakama, M, Louhivuori, K 1988A screening programme for cervical cancer that workedCancer Surv7403416PubMed
9.
Parkin, DM, Nguyen-Dinh, X, Day, NE 1985The impact of screening on the incidence of cervical cancer in England and WalesBr J Obstet Gynaecol92150157PubMed
10.
Macgregor, JE, Campbell, KM, Mann, EMF, Swanson, KY 1994Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive diseaseBMJ30814071411PubMed
11.
Gibson, L, Spiegelhalter, DJ, Camilleri-Ferrante, C,  et al. 1997Trends in invasive cervical cancer incidence in East Anglia from 1971 to 1993J Med Screen44448PubMed
12.
Quinn, M, Babb, P, Jones, J, Allen, A 1999Effect of screening on incidence of and mortality from cancer of the cervix in England: evaluation based on routinely collected statisticBMJ318904908PubMed
13.
Peto, J, Gilham, C, Fletcher, O, Matthews, FE 2004The cervical cancer epidemic that screening has prevented in the UKLancet364249256CrossRefPubMed
14.
Liu, S, Semenciw, R, Probert, A, Mao, Y 2001Cervical cancer in Canada: changing patterns in incidence and mortalityInt J Gynecol Cancer112431CrossRefPubMed
15.
Laara, E, Day, NE, Hakama, M 1987Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmesLancet112471249PubMed
16.
Aareleid, T, Pukkala, E, Thomson, H,  et al. 1993Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened populationEur J Cancer29745749CrossRef
17.
Sigurdsson, K 1999The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995Acta Obstet Gynecol Scand78478485PubMed
18.
McCredie, M, Coates, MS, Ford, JM 1989Trends in invasive cancer of the cervix uteri in New South Wales, 1973–1982Aust NZ J Obstet Gynaecol29335339
19.
McCredie, M, Coates, M, Churches, T 1990Cancer of the Cervix Uteri: New South Wales, Australian Capital Territory 1972–1987Cancer Epidemiology Research Unit and NSW Central Cancer Registry, NSW Cancer CouncilSydney
20.
Kricker, A, Bell, J, Coates, M, Taylor, R, Armstrong, B 1996Cancer of the Cervix in NSW 1972 to 1992Cancer Epidemiology Research Unit and NSW Central Cancer Registry, NSW Cancer CouncilSydney
21.
Taylor, R, Bell, J, Coates, M, Churches, T, Wain, G 1996Cervical cancer in New South Wales women: five-year survival, 1972 to 1991ANZ J Pub Health20413420
22.
Australian Institute of Health and Welfare [AIHW] (1998) Breast and cervical cancer screening in Australia 1996–1997. AIHW Cat. No. CAN 3 (Cancer Series Number 8). AIHW Canberra
23.
New South Wales Cervical Screening Program and NSW Pap Test Register [NSW CSP/PTR] (1999) Cervical cancer screening in New South Wales: First Annual Statistical report 1997. NSW Health Department, Sydney. http://​www.​csp.​nsw.​gov.​au
24.
Coates M, et al. (1992–1998) Cancer in NSW, Incidence and Mortality [1990–1995, annual reports]. NSW Central Cancer Registry and Cancer Control Information Centre, NSW Cancer Council and NSW Health Department
25.
Tracey E, et al. (2003) Cancer in NSW, Incidence and Mortality 2001 [2001 annual report]. NSW Central Cancer Registry, Cancer Research and Registers Division; NSW Cancer Council; and NSW Health Department
26.
Taylor, R, Morrell, S, Mamoon, H, Wain, G 2001The effect of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohortJ Epi Com Hlth55782788
27.
Muir, C, Waterhouse, J, Mack, T,  et al. 1987Cancer Incidence in Five ContinentsInternational Agency for Research on CancerLyon45IARC Publication No 88.
28.
Armitage, P, Berry, G 1994Statistical Methods in Medical Research3Blackwell Scientific PublicationsOxford
29.
Yu, XQ, O'Connell, DL, Gibberd, RW, Smith, DP, Armstrong, BK 2003Cancer Survival, Incidence and Mortality by Area Health Service in NSW 1994–2000NSW Cancer CouncilSydney
30.
New South Wales Cervical Screening Program and NSW Pap Test Register [NSW CSP/PTR] (2003) Cervical cancer screening in New South Wales: Annual Statistical report 2002. NSW Health Department, Sydney. http://​www.​csp.​nsw.​gov.​au
Metadata
Title
Decline in Cervical Cancer Incidence and Mortality in New South Wales in Relation to Control Activities (Australia)
Authors
Richard Taylor
Stephen Morrell
Hassan Mamoon
Gerard Wain
Jayne Ross
Publication date
01-04-2006
Publisher
Kluwer Academic Publishers
Published in
Cancer Causes & Control / Issue 3/2006
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-005-0515-z

Other articles of this Issue 3/2006

Cancer Causes & Control 3/2006 Go to the issue

Original Paper

PPARγ and Colon and Rectal Cancer: Associations with Specific Tumor Mutations, Aspirin, Ibuprofen and Insulin-Related Genes (United States)

Original Paper

A Pooled Analysis of 12 Cohort Studies of Dietary Fat, Cholesterol and Egg Intake and Ovarian Cancer

Review Article

Opportunities and Barriers in the Age of Team Science: Strategies for Success

Original Paper

COX-2 Polymorphism, Use of Nonsteroidal Anti-Inflammatory Drugs, and Risk of Colon Cancer in African Americans (United States)

Original Paper

Breast Cancer Survival among South Asian Women in California (United States)

Original Paper

Regular Use of Aspirin and Prostate Cancer Risk (United States)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits